Lynparza.com

Website Ranking Data
Current Alexa Rank

628,921

Updated Feb 01 2023
Historical Rank
Estimated Visitors

4,837

Daily Unique Visitors

149,958

Monthly Visitors

1,799,496

Yearly Visitors
Name Server Information
ns-1068.awsdns-05.org
ns-17.awsdns-02.com
ns-1948.awsdns-51.co.uk
ns-940.awsdns-53.net
Web Server Information
IP Address 52.84.27.11
Server Response 200
Web Server astrazeneca.com
Top related sites:
Meta Tags and Data
Title
LYNPARZA® (olaparib) | Targeted Cancer Therapy
Meta Description
LYNPARZA® (olaparib) is approved for use in recurrent ovarian cancer and gBRCA HER2-negative metastatic breast cancer.
Meta Keywords
Technologies in use
Google Analytics, jQuery, jQuery UI, Modernizr, SiteCatalyst, Underscore.js
Server Response
Content-Typetext/html; charset=UTF-8
Connectionkeep-alive
Access-Control-Allow-Originhttps://policy.cookiereports.com
Cache-Controlno-cache="set-cookie"
Content-Encodinggzip
ExpiresThu, 01 Jan 1970 00:00:00 GMT
Serverastrazeneca.com
X-Content-Type-Optionsnosniff
X-Frame-OptionsSAMEORIGIN
X-Powered-ByAstrazeneca
X-XSS-Protection1; mode=block
VaryAccept-Encoding,User-Agent
X-CacheMiss from cloudfront
Via1.1 e364a215258bbfb310702eaedcb82e22.cloudfront.net (CloudFront)
X-Amz-Cf-IdJmx3xMIgKjsIjivh3mvspjVWy4Brm88JLUhkbU0VBUUrAW-H9noxnQ==